Maintenance steroid therapy is associated with decreased risk of malignancy and better prognosis of patients with autoimmune pancreatitis: A multicenter cohort study in Japan
Pancreatology · 2024-05 · 24 (3) · 335-342
DOI: 10.1016/j.pan.2024.01.008 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Pancreatology, 2024-05. Verfasst von Tetsuya Takikawa und 29 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Japan. Hauptthemen laut MEDLINE: Autoimmune Pancreatitis, Autoimmune Diseases, Diabetes Mellitus, Pancreatic Neoplasms. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Japan Pancreas Society, Government of Japan Ministry of Health Labour and Welfare.
Abstract (Originalsprache)
BACKGROUND/OBJECTIVES: The association between autoimmune pancreatitis (AIP) and pancreatic cancer (PC) remains controversial. This study aimed to clarify the long-term prognosis and risk of malignancies in AIP patients in Japan. METHODS: We conducted a multicenter retrospective cohort study on 1364 patients with type 1 AIP from 20 institutions in Japan. We calculated the standardized incidence ratio (SIR) for malignancies compared to that in the general population. We analyzed factors associated with overall survival, pancreatic exocrine insufficiency, diabetes mellitus, and osteoporosis. RESULTS: The SIR for all malignancies was increased (1.21 [95 % confidence interval: 1.05-1.41]) in patients with AIP. Among all malignancies, the SIR was highest for PC (3.22 [1.99-5.13]) and increased within 2 years and after 5 years of AIP diagnosis. Steroid use for ≥6 months and ≥50 months increased the risk of subsequent development of diabetes mellitus and osteoporosis, respectively. Age ≥65 years at AIP diagnosis (hazard ratio [HR] = 3.73) and the development of malignancies (HR = 2.63), including PC (HR = 7.81), were associated with a poor prognosis, whereas maintenance steroid therapy was associated with a better prognosis (HR = 0.35) in the multivariate analysis. Maintenance steroid therapy was associated with a better prognosis even after propensity score matching for age and sex. CONCLUSIONS: Patients with AIP are at increased risk of developing malignancy, especially PC. PC is a critical prognostic factor for patients with AIP. Although maintenance steroid therapy negatively impacts diabetes mellitus and osteoporosis, it is associated with decreased cancer risk and improved overall survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Japan.
- Third Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
- Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
- Department of Medicine, Division of Gastroenterology and Hepatology, Shinshu University School of Medicine, Matsumoto, Japan.
- Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
- Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Förderung
- Japan Pancreas Society
- Government of Japan Ministry of Health Labour and Welfare
Zitieren
APA
Takikawa, T., Kikuta, K., Sano, T., Ikeura, T., Fujimori, N., Umemura, T., Naitoh, I., Nakase, H., Isayama, H., Kanno, A., Kamata, K., Kodama, Y., Inoue, D., Ido, A., Ueki, T., Seno, H., Yasuda, H., Iwasaki, E., Nishino, T., …, & Japan Pancreatitis Study Group for AIP (2024). Maintenance steroid therapy is associated with decreased risk of malignancy and better prognosis of patients with autoimmune pancreatitis: A multicenter cohort study in Japan. Pancreatology, 24(3), 335-342. https://doi.org/10.1016/j.pan.2024.01.008
Vancouver
Takikawa T, Kikuta K, Sano T, Ikeura T, Fujimori N, Umemura T, et al. Maintenance steroid therapy is associated with decreased risk of malignancy and better prognosis of patients with autoimmune pancreatitis: A multicenter cohort study in Japan. Pancreatology. 2024;24(3):335-342. doi:10.1016/j.pan.2024.01.008
BibTeX
@article{Takikawa2024,
author = {Takikawa, Tetsuya and Kikuta, Kazuhiro and Sano, Takanori and Ikeura, Tsukasa and Fujimori, Nao and Umemura, Takeji and Naitoh, Itaru and Nakase, Hiroshi and Isayama, Hiroyuki and Kanno, Atsushi and Kamata, Ken and Kodama, Yuzo and Inoue, Dai and Ido, Akio and Ueki, Toshiharu and Seno, Hiroshi and Yasuda, Hiroaki and Iwasaki, Eisuke and Nishino, Takayoshi and Kubota, Kensuke and Arizumi, Toshihiko and Tanaka, Atsushi and Uchida, Kazushige and Matsumoto, Ryotaro and Hamada, Shin and Nakamura, Seiji and Okazaki, Kazuichi and Takeyama, Yoshifumi and Masamune, Atsushi and Japan Pancreatitis Study Group for AIP, Japan Pancreatitis Study Group for AIP},
title = {Maintenance steroid therapy is associated with decreased risk of malignancy and better prognosis of patients with autoimmune pancreatitis: A multicenter cohort study in Japan},
journal = {Pancreatology},
year = {2024},
volume = {24},
number = {3},
pages = {335--342},
doi = {10.1016/j.pan.2024.01.008}
}
EUVIMED